XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Interim Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Research and development $ (1,706) $ (1,119)
General and administrative (1,470) (1,273)
Operating loss (3,176) (2,392)
Financing income (expenses), net (13) 4
Net loss $ (3,189) $ (2,388)
Basic and diluted net loss per share $ (0.45) $ (0.34)
Basic and diluted weighted average common shares outstanding 7,108,133 7,108,133